An Essential Review of Multiple Sclerosis for Healthcare Professionals

Supported by educational grants from Celgene and Sanofi Genzyme

TITLE - An Essential Review of Multiple Sclerosis for Healthcare Professionals

TARGET AUDIENCE - Target audiences for this program are Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, and Neurology Pharmacists

LEARNING OBJECTIVES - After completing the program, Specialty Pharmacists, Pharmacists, Clinical Pharmacists, Specialty Pharmacy executives, Pharmacy Directors, Chief Pharmacy Officers, and Neurology Pharmacists

  1. Describe the latest understanding of the etiology and pathophysiology of multiple sclerosis (MS)
  2. Review the prevalence and epidemiology of MS
  3. Recognize the classification of MS and common signs and symptoms
  4. Discuss the importance of early identification and the incidence of misdiagnosis
  5. Describe updated diagnostic criteria for MS
  6. Discuss the scale used to grade MS-related disability
  7. Review pharmacologic and non-pharmacologic management strategies for MS patients

Faculty Disclosures:

Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/ services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by the Specialty Pharma Education Center for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Pharmacist continuing education credit

Specialty Pharma Education Center (SPEC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 1.5 hours (0.15CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
ACPE #0535-0000-19-018-H01-P

Knowledge Based Activity

Course release date 5/10/2019

Course expires 5/10/2022

Credit Information

Activity Number Credit Amount Accreditation Period
0535-0000-19-018-H01-P 0.15 CEUs May 10, 2019 - May 10, 2022